Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone acetonide 10 mg vs 20 mg injection for de Quervain tenosynovitis
TCTR20240429004Phase 4Unknown
- Sponsor
- Phramongkutklao Hospital Foundation
- Start
- May 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone acetonide in de Quervain's tenosynovitis, sponsored by Phramongkutklao Hospital Foundation. Status: unknown.
02
Drugs
triamcinolone acetonide
03
Conditions
de Quervain's tenosynovitis
Beyond the preview
Go deeper on TCTR20240429004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240429004.